Fully automated, quality-controlled cardiac analysis from CMR:validation and large-scale application to characterize cardiac function by Ruijsink, Jacobus Bernardus et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
/10.1016/j.jcmg.2019.05.030
Document Version
Version created as part of publication process; publisher's layout; not normally made publicly available
Link to publication record in King's Research Portal
Citation for published version (APA):
Ruijsink, J. B., Puyol Anton, E., Oksuz, I., Sinclair, M., Bai, W., Schnabel, J. A., ... King, A. P. (2019). Fully
automated, quality-controlled cardiac analysis from CMR: validation and large-scale application to characterize
cardiac function. JACC Cardiovascular Imaging. https://doi.org//10.1016/j.jcmg.2019.05.030
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 09. Jul. 2020
J A C C : C A R D I O V A S C U L A R I M A G I N G VO L . - , N O . - , 2 0 1 9
C R OWN CO P Y R I G H T ª 2 0 1 9 P U B L I S H E D B Y E L S E V I E R O N B E H A L F O F T H E A M E R I C A N
C O L L E G E O F C A R D I O L O G Y F O UN DA T I O N . T H I S I S A N O P E N A C C E S S A R T I C L E U N D E R T H E
C C B Y L I C E N S E ( h t t p : / / c r e a t i v e c o mm o n s . o r g / l i c e n s e s / b y / 4 . 0 / ) .ORIGINAL RESEARCHFully Automated, Quality-Controlled
Cardiac Analysis From CMR
Validation and Large-Scale Application to
Characterize Cardiac FunctionBram Ruijsink, MD, PHD,a,b,* Esther Puyol-Antón, PHD,a,* Ilkay Oksuz, PHD,a Matthew Sinclair, PHD,a
Wenjia Bai, PHD,c,d Julia A. Schnabel, PHD,a Reza Razavi, MD, PHD,a,b Andrew P. King, PHDaABSTRACTISS
Fro
bD
Kin
an
con
Me
NI
NH
(ap
pro
the
MaOBJECTIVES This study sought to develop a fully automated framework for cardiac function analysis from
cardiac magnetic resonance (CMR), including comprehensive quality control (QC) algorithms to detect erroneous
output.
BACKGROUND Analysis of cine CMR imaging using deep learning (DL) algorithms could automate ventricular function
assessment. However, variable image quality, variability in phenotypes of disease, and unavoidable weaknesses in
training of DL algorithms currently prevent their use in clinical practice.
METHODS The framework consists of a pre-analysis DL image QC, followed by a DL algorithm for biventricular
segmentation in long-axis and short-axis views, myocardial feature-tracking (FT), and a post-analysis QC to detect
erroneous results. The study validated the framework in healthy subjects and cardiac patients by comparison against
manual analysis (n¼ 100) and evaluation of the QC steps’ ability to detect erroneous results (n¼ 700). Next, this method
was used to obtain reference values for cardiac function metrics from the UK Biobank.
RESULTS Automated analysis correlated highly with manual analysis for left and right ventricular volumes (all r> 0.95),
strain (circumferential r ¼ 0.89, longitudinal r > 0.89), and filling and ejection rates (all r $ 0.93). There was no
significant bias for cardiac volumes and filling and ejection rates, except for right ventricular end-systolic volume
(bias þ1.80 ml; p ¼ 0.01). The bias for FT strain was <1.3%. The sensitivity of detection of erroneous output was 95% for
volume-derived parameters and 93% for FT strain. Finally, reference values were automatically derived from 2,029 CMR
exams in healthy subjects.
CONCLUSIONS The study demonstrates a DL-based framework for automated, quality-controlled characterization of
cardiac function from cine CMR, without the need for direct clinician oversight. (J Am Coll Cardiol Img 2019;-:-–-)
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ABBR EV I A T I ON S
AND ACRONYMS
ε = myocardial strain
AC = atrial contribution
CMR = cardiac magnetic
resonance
CNN = convolutional neural
network
DL = deep learning
EDV = end-diastolic volume
EF = ejection fraction
ESV = end-systolic volume
FT = feature tracking
LAX = long-axis
LV = left ventricle/ventricular
LVM = left ventricular mass
QC = quality control
RV = right ventricle/ventricular
SAX = short-axis
SV = stroke volume
SVM = support vector machine
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2C ardiac magnetic resonance (CMR)enables full coverage of the heartusing high spatial and temporal res-
olution, without the constraints of limited
acquisition windows or use of ionizing radia-
tion, as with echocardiography or computed-
tomography (1). Cine CMR has become the
gold standard for non-invasive quantification
of cardiac volumes and ejection fraction (EF)
(1). However, cine CMR images hold signifi-
cantly more detailed information that allow
for quantification of advanced markers of
cardiac function such as ventricular shape
(2), ejection and filling rates (3), myocardial
wall motion, and myocardial strain (ε) (4,5).
These parameters have shown to be valuable
biomarkers for earlier detection and moni-
toring of disease (2–5). However, obtaining
them is time and labor intensive. Moreover,
although largescale studies have provided
meaningful reference values and standards
for analysis of cardiac volumes and EF (6,7),
such studies are absent for the remainingbiomarkers. As a result, the use of these advanced
markers in clinical practice has so far been limited.
Recent advances in deep learning (DL) algorithms
show great promise for the automation of CMR anal-
ysis. Convolutional neural networks (CNNs), have
achieved previously unmatched accuracy in many
image analysis challenges (8). Using CNNs, a wide set
of cardiac functional parameters could potentially be
obtained automatically from CMR. Several groups
have shown that CNNs can provide accurate end-
diastolic and end-systolic cardiac segmentations
from CMR in preselected images (9–11). Although
these results have gained significant attention, the
practical implementation of DL algorithms in clinical
practice and research is hindered by a lack of appro-
priate quality control (QC). Variable image quality,
image artefacts, and unusual anatomic variations (not
seen during training) are unavoidable in clinical
imaging, and can result in significant errors if such
images are analyzed automatically. Therefore, robust
QC measures to detect (potential) erroneous output
are a prerequisite to the translation of DL algorithms
into clinical practice (12).
We aim to address this issue by developing a
pipeline for comprehensive analysis of cardiac func-
tion (cardiac volumes, filling and ejection dynamics
and myocardial strain) that includes robust QC
mechanisms, which allows for automated cine CMR
analysis without clinician oversight. Using our pipe-
line, we provide reference values for a range ofautomatically derived cardiac metrics that have not
previously been reported in large subject cohorts.
METHODS
IMAGE ANALYSIS PIPELINE. The developed image
analysis pipeline consists of a DL algorithm for seg-
mentation of short-axis (SAX) and 2- and 4-chamber
long-axis (LAX) cine CMR stacks, automated calcula-
tion of cardiac functional parameters and 2 QC steps:
1 before the segmentation and analysis steps (QC1)
and 1 after (QC2). For an illustration of the pipeline
see the Central Illustration and Video 1. Our pipeline is
available for further training and use via the corre-
sponding author.
STEP 1: PRE-ANALYSIS IMAGE QC (QC1). All CMR
images were screened for the presence of motion ar-
tefacts (artefacts due to inconsistent breath-holding,
mistriggering or arrhythmias) and erroneous plan-
ning of the 4-chamber view using 2 CNNs: a 2-
dimensional CNN with a recurrent long short-term
memory layer trained to detect motion artefacts and
a 2-dimensional CNN trained to detect erroneous
planning of the 4-chamber view (CNN4Ch). We have
previously published a detailed description of the
architecture, training, and validation of both algo-
rithms (13,14).
STEP 2: IMAGE SEGMENTATION. After QC1, a 17-layer
CNN (CNNsegment) was used to segment the left
ventricle (LV) and right ventricle (RV), including the
LV myocardium, in all frames of the cine CMR. This
network has been trained using manual segmenta-
tions of cine CMR images in 3,975 subjects, consisting
of both healthy volunteers as well as patients with a
wide variety of cardiac diseases (10).
STEP 3: PARAMETER CALCULATION. After segmen-
tation, the SAX and LAX imaging stacks were aligned
using an iterative alignment process to correct for
different breath-hold positions and motion between
the different cine-acquisitions (15). Next, LV and RV
volume curves and LV mass (LVM) were calculated.
From the volume curves, end-diastolic volume (EDV),
end-systolic volume (ESV), stroke volume (SV), EF,
peak ejection rate, peak early filling rate, atrial
contribution (AC), and peak atrial filling rate were
obtained.
Subsequently, CMR feature tracking (FT) was
automatically performed on 3 SAX slices, and the
2- and 4-chamber LAX images. We previously pub-
lished the details of this method (16). Briefly, CMR FT
was performed using the Medical Image Registration
ToolKit. The end-diastolic LV wall segmentations
were used as the region of interest for the FT
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An animation of the pipeline is shown in Supplemental Video 1. LV ¼ left ventricle; QC ¼ quality control; RV ¼ right ventricle.
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4algorithm. Global circumferential strain (εcirc), radial
strain (εrad), and longitudinal strain (εlong) were
computed from the FT results.
STEP 4: POST-ANALYSIS QC (QC2). In QC2, we first
evaluated the orientation of the images, the presence
of missing slices, and the coverage of the segmenta-
tions over the heart. We automatically compared the
aligned LAX and SAX images and segmentations to
determine the image plane intersections (e.g., did the
LAX images intersect the mitral valve and apex in
SAX?), presence of missing slices (e.g., did the SAX
stack cover the full length of the LAX segmentation?),
and the coverage of segmentations (did LAX seg-
mentation reach a similar level as the SAX segmen-
tation and vice versa?). Next, the output parameters
were inspected. If there was a >10% difference be-
tween LV and RV SV or a >10% difference between
ventricular volumes on the first and last cardiac
phase, the exams were flagged. Lastly, we imple-
mented 2 support vector machine (SVM) classification
algorithms to detect abnormalities in the obtained
volume (SVMvol) and strain curves (SVMstrain). These
SVMs were trained using output of the CNNsegment
and FT algorithm from 500 UK Biobank subjects (300
healthy subjects and 200 subjects with cardiomyop-
athy). These datasets were classified by an expert
CMR cardiologist as right or wrong/unusual on the
basis of the shape of the volume and strain curves, as
well as the corresponding functional parameters.
All cases detected during the QC steps were flagged
for clinician review.
PIPELINE VALIDATION. We validated our method in
2 ways. First, we compared the results obtained to
manual analysis by an experienced CMR cardiologist
(Validation1) in 50 healthy volunteers and 50 patients
with cardiomyopathy. These cases were not previ-
ously used during training of the algorithms and were
randomly selected after having successfully passed
the algorithm’s QC steps. During the manual analysis,
ventricular volumes were segmented at each cardiac
phase using commercially available CMR analysis
software, CVi42 (Version 5.10.1, Circle, Calgary,
Alberta, Canada). With the same software, CMR FT
was performed to obtain strain values.
Secondly, we evaluated the ability of the full
pipeline to detect errors in the analysis (Validation2)
in a further 700 cases (500 healthy subjects and 200
patients with cardiomyopathy) randomly selected
from the UK Biobank cohort, again excluding cases
used during training. An experienced CMR cardiolo-
gist, blinded for the pipeline’s verdict, critically
reviewed the segmentations, volume and strain
curves and parameters obtained in step 3 andclassified them as correct or erroneous. This process
was facilitated by visually representing the images
with segmentations and outcome-parameters for
each case in a single panel to ensure apt identification
of errors (Supplemental Figure 1, Video 2).
OBTAINING REFERENCE VALUES. After validation,
we utilized the developed pipeline to obtain refer-
ence values. Healthy subjects were selected from a
total of 9,619 cases in the UK Biobank that underwent
CMR (17), excluding all subjects with a history of
cardiovascular disease, cardiovascular risk factors,
other systemic diseases, those taking medication for
any systemic disease, and subjects with a body mass-
index >30 kg/m2 (see all exclusion criteria in
Supplemental Table 1).
STATISTICS. Validation1. Dice coefficients were
calculated to compare the manual and automated
segmentations. Bland-Altman analysis and Pearson’s
correlations were used to compare the obtained car-
diac volumes, filling and ejection rates, and peak
global strains to the manual analysis. To verify the
significance of the biases, paired t-tests versus zero
values were applied. Finally, we compared the mean
absolute errors of all parameters between healthy
subjects and patients with disease using paired
t-tests.
Validation2. Sensitivity (% of manually labelled erro-
neous output that was correctly detected by the
pipeline during QC), specificity (% of output manually
labelled as error-free that was not flagged by the
pipeline during QC), and balanced accuracy were
calculated for the total pipeline’s performance for
volume and strain analysis, as well as for each indi-
vidual parameter.
Reference values. Data were stratified by sex, and age
by decade (45 to 54, 55 to 64, and 65 to 74 years), and
the means and reference ranges (95% prediction in-
tervals) were defined (18). Outliers, defined a priori as
values 3 interquartile ranges below the first or above
the third quartile, were removed from the analysis.
Cardiac volumes were indexed to body surface area
using the Dubois and Dubois formula (19). We used
linear regression analysis to assess the impact of age
on ventricular volumes, filling and ejection dynamics
and strains. For all analyses, p values were corrected
using Bonferroni correction for multiple comparisons.
A p value of <0.05 after correction was considered
statistically significant.
RESULTS
VALIDATION1. Overall, the Dice score between
manual and automated segmentations was 0.93 
0.03% for the LV blood pool, 0.84  0.02% for the LV
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5myocardium, and 0.91  0.03% for the RV blood pool
segmentations. There was a good correlation between
automatically and manually obtained cardiac vol-
umes (LVEDV r ¼ 0.99; LVESV r ¼ 0.98; LVM r ¼ 0.94;
RVEDV r ¼ 0.98; and RVESV r ¼ 0.91), filling and
ejection parameters (peak ejection rate r ¼ 0.98; peak
early filling rate r ¼ 0.98; peak atrial filling rate
r ¼ 0.97 and AC r ¼ 0.93) and strain (εcirc r ¼ 0.91; εrad
r ¼ 0.85; εlong 2-chamber r ¼ 0.91; and εlong 4-chamber
r ¼ 0.89). The Bland-Altman plots for agreement be-
tween the pipeline and manual analysis are shown in
Figures 1 and 2. There was no significant bias for car-
diac volumes and filling and ejection parameters,
except for RVESV (bias þ1.80 ml; 2.3% of the mean
RVESV; p ¼ 0.01) and LVM (bias þ2.95 ml; 2.7% of the
mean LVM; p ¼ 0.001). For strain, there was a sig-
nificant bias for εcirc (þ0.75%; p < 0.001) and 2- and
4-chamber εlong (þ1.29%; p < 0.001 and þ1.03%;
p < 0.001, respectively). Lastly, there was no signifi-
cant difference in mean absolute error between car-
diac patients and healthy volunteers for the output
parameters, except for LVESV (4.04  4.04 ml vs. 6.65
 5.90 ml; p < 0.01) and AC (2.19  2.17 ml vs. 3.30 
2.31 ml; p < 0.01) (Supplemental Table 2).
VALIDATION2. Table 1 shows the results of Valida-
tion2. For the total pipeline, sensitivity for volume
parameters (volume curves, cardiac volume, and
filling and ejection dynamics) was 94.99%, whereas
the specificity was 82.93%. Stratified by group, the
sensitivity was 94.83% in healthy subjects and
95.39% in cardiac patients. For strain assessment,
sensitivity and specificity were 93.21% and 77.14%,
respectively, and sensitivity for each subgroup was
92.69% in healthy subjects and 94.41% in cardiac
patients. Supplemental Table 3 shows data for all the
individual parameters. The total rate of CMRs flagged
by the QCs was 26% in healthy volunteers and 32% in
cardiac patients. The final rejection rate of the pipe-
line after clinician review was 15.2% for healthy sub-
jects and 11% for the cardiac patients.
OBTAINED REFERENCE VALUES. A total of 2,029
subjects of the UK Biobank matched our criteria for
healthy subjects and were processed using our pipe-
line (Supplemental Figure 2). During QC1, 222 cases
(11%) were rejected for image quality. During QC2, 75
exams (4%) were automatically flagged for errors in
cardiac volume output, whereas 119 (7%) were flagged
for errors in strain analysis. Baseline characteristics of
the remaining subjects are shown in Table 2. Refer-
ence values for cardiac volumes, cardiac function and
filling and ejection parameters as well as εcirc, εlong,
and εrad stratified by sex are shown in Tables 3 and 4.
Supplemental Table 4 shows the regression analysisof changes in cardiac function in men and women
with age.
DISCUSSION
In this study, we presented and validated a pipeline
for automated analysis of ventricular function from
cine CMR. Our pipeline is not solely a DL image anal-
ysis algorithm, but a framework that includes exten-
sive QC steps to allow fully automatic processing of
large numbers of CMR datasets without direct clini-
cian oversight. We show that, using our proposed
technique, we were able to obtain a detailed descrip-
tion of cardiac function in >2,000 healthy individuals.
To the authors’ best knowledge, this is the first
comprehensive framework for automated cine CMR
analysis that approaches clinical standards of QC.
AUTOMATED QC. QC is essential in developing DL
algorithms for automated processing of clinical data,
but has so far been mostly overlooked (12). In our
framework, we implemented QC in 2 separate steps, a
pre-analysis control of image quality, QC1, and a post-
analysis control of the quality of the output parame-
ters, QC2.
QC1 focused on detection of motion artefacts and
off-axis planning of the obtained images. Motion ar-
tefacts do not result in static distortion of the image,
which is easily recognized in post-analysis QC.
Instead, the dynamic motion of the heart is affected
due to incorporation of information from unrepre-
sentative motion states (arrhythmias or mistriggering)
or through- and in-plane motion (breathing artefacts).
Similar to off-axis planning, these artefacts can have a
significant impact on the computed parameters.
In QC2, we used a wide range of relevant criteria to
evaluate the output of our pipeline, including clinical
knowledge (similarity between LV and RV SV),
anatomical relations (coverage of segmentations and
images in LAX and SAX) and DL algorithms. This
design ensured that erroneous and/or anomalous
outputs were detected independent of their nature,
even in cases not anticipated during development of
the algorithms. This generalization facilitates imple-
mentation of the pipeline in clinical scenarios, such
as large research databases or clinical practice, where
the image quality and disease are not known a priori.
Techniques for automated QC have been previ-
ously proposed, such as motion artefact detection in
brain magnetic resonance imaging (20), image quality
evaluation in fetal (21) and cardiac (22) ultrasound,
and detection of missing slices (23), off-axis planning
(24), or segmentation errors (25) in CMR. So far, these
techniques have been aimed at a single source of er-
ror and lack a generalized QC of the output based on
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FIGURE 2 Bland-Altman Plots for LV Filling and Ejection and Global Peak Strain Parameters
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TABLE 1 Results of Validation2
Validation Total Pipeline
Sensitivity, % Specificity, % BACC, %
Volumes
Healthy subjects 94.83 86.57 90.70
Cardiac patients 95.39 76.78 86.09
Overall 94.99 82.93 88.96
Strains
Healthy subjects 92.69 77.34 85.02
Cardiac patients 94.41 76.65 85.53
Overall 93.21 77.14 85.18
Sensitivity, specificity and balanced accuracy (BACC) of the pipeline in detecting inaccurate or
unusual output versus correct output with respect to manual assessment are shown.
TABLE 2
Analysis f
Age, yrs
Male
Systolic b
Diastolic b
Heart rate
Weight, kg
Height, cm
Body surfa
Body mas
Values are m
Ruijsink et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . - , N O . - , 2 0 1 9
Fully Automated, Quality-Controlled Cardiac Function From Cine CMR - 2 0 1 9 :- –-
8clinical criteria. Robinson et al. (25) proposed a
method to obtain segmentation quality scores for SAX
segmentations from previous ratings in a large cohort
of CMR segmentations. Obtaining quality scores from
segmentations using this method, or other techniques
that include uncertainty into segmentation networks,
can complement our framework to further improve
the quality of automated CMR analysis.
PIPELINE VALIDATION. We validated the perfor-
mance of the pipeline in 2 separate steps (Validation1
and Validation2). The direct comparison between
automated and manual analysis in Validation1
demonstrated that the data obtained using our
method was in high agreement for both segmenta-
tions (see Dice scores in Results subsection
‘Validation1’) as well as output (Figures 1 and 2). Only
for LVM (þ2.95 g), RVESV (þ1.80 ml), and εcirc and
ε
long strain (þ0.75% and þ1.03% to 1.29%, respec-
tively) was there a small bias. However, these biases
are within the range of inter- and intraobserver vari-
abilities previously reported (6,26) and are unlikely to
have significant clinical impact. The validation resultsBaseline Characteristics of the Healthy Subjects Included in the
or Reference Values
Age Groups, yrs
45–54
(n ¼ 601)
55–64
(n ¼ 706)
65–74
(n ¼ 454)
50  2 59  2 67  2
304 (50.58) 384 (54.39) 241 (53.08)
lood pressure, mm Hg 125  11 130  14 137  15
lood pressure, mm Hg 76  7 77  8 78  8
, beats/min 59  8 60  9 59  8
74  11 73  12 74  10
171  8 171  12 172  8
ce area, m2 1.87  0.19 1.86  0.18 1.87  0.17
s index, kg/m2 25.0  2.7 24.8  2.6 25.0  2.6
ean  SD or n (%).for cardiac volumes (EDV, ESV, and SV) correspond
well to the ones obtained in the original publication of
the CNNsegment (10), showing its reproducibility. The
Dice scores we obtained were slightly lower compared
with the original publication of the segmentation
network. The original network was trained and tested
on segmentations made by the UK Biobank’s core
analysis lab (6). In our paper, validation was per-
formed against a new set of ground truth segmenta-
tions, performed by our own CMR cardiologists. The
lower performance is therefore likely a reflection of
the slight differences in training paradigms and seg-
mentation strategies between cardiac CMR centers.
To investigate the detection of erroneous data by
the QC steps of our image-processing pipeline, we
evaluated its performance in a second, larger popu-
lation. Manual analysis of all 700 cases in Validation2
is practically unrealistic. Therefore, we focused on
critical review of the segmentations and output pa-
rameters to score their validity and evaluated the
pipeline’s ability to detect the erroneous cases.
The results of Validation2 show that our 2-step QC
robustly detects potential erroneous cases. Overall,
the sensitivity of the pipeline to detect errors was high
for both volume curves (94.99%) and strain (93.21%).
The specificity of the pipeline to correctly detect
good cases was lower (82.93% for volume curves and
77.14% for strain). This is likely a consequence of the
stringent QC criteria, resulting in flagging of cases
with severely distorted anatomy (for example, after
cardiac surgery) or abnormal volume curves
(restricted ventricles with small volumes, low EF, and
shallow early diastolic upslope of the curve).
Although the lower specificity leads to unnecessary
clinician review, we viewed it necessary to flag such
cases to create a safe clinical workflow. However, the
additional time for manual review is minimal because
incorrectly flagged cases can be directly accepted
upon review without adjustments.
It is noteworthy that, except for the lower speci-
ficity, our method performed similarly well in pa-
tients with cardiomyopathy as in healthy subjects,
see the comparisons of absolute mean errors in vali-
dation1 (Supplemental Table 2) and sensitivity of er-
ror detection in validation2 (Table 1, Supplemental
Table 3). Only for LVSV and AC were there small dif-
ferences in mean absolute errors, but these are un-
likely to have significant clinical impact. As can be
appreciated from the Bland-Altman plots, the errors
did not significantly increase at very high or very low
values of the parameters. This further shows that the
network has been robustly trained and is also
accurate in outliers, such as patients with severe
ventricular dilatation.
TABLE 3 Reference Values for Men by Automated Cine CMR Analysis
Age Groups, yrs
45–54 55–64 65–74
Lower Mean Upper Lower Mean Upper Lower Mean Upper
Left ventricle
Volumes
LV end-diastolic volume, ml 127 179 231 122 175 227 127 170 213
LV end-systolic volume, ml 48 77 106 46 73 99 51 72 93
LV stroke volume, ml 68 103 137 68 102 136 68 99 129
LV mass, g 71 104 137 73 100 126 74 98 123
Indexed LV end-diastolic volume, ml/m2 66 90 114 64 89 114 67 88 110
Indexed LV end-systolic volume, ml/m2 25 39 52 25 37 50 27 37 48
Indexed LV stroke volume, ml/m2 36 52 68 35 52 70 36 51 67
Indexed LV mass g/m2 38 52 66 39 51 63 40 51 61
LV ejection fraction, % 48 57 67 49 58 67 49 58 66
LV mass-to-volume ratio, g/ml 0.47 0.58 0.70 0.46 0.57 0.68 0.44 0.58 0.71
Filling and ejection dynamics
Peak ejection rate, ml/s 362 502 643 343 483 623 329 466 604
Peak early filling rate, ml/s 239 417 594 202 369 537 167 332 496
Peak atrial filling rate, ml/s 77 254 431 102 269 436 63 222 382
Atrial contribution, ml 12 32 53 15 34 54 7 27 46
Atrial contribution, % of SV 10 32 54 18 34 50 6 28 50
Peak global strain
Circumferential strain SAX, % 14 18 26 14 19 26 15 19 25
TPK circumferential SAX, ms 280 341 423 279 339 420 291 340 408
Radial strain SAX, % 27 41 68 30 44 66 28 45 70
TPK radial SAX, ms 276 334 413 276 330 403 286 335 403
Longitudinal strain 2CH, % 11 16 22 11 16 22 11 16 23
TPK longitudinal 2CH, ms 288 360 451 283 358 452 300 353 446
Longitudinal strain 4CH, % 10 15 21 9 15 21 10 16 22
TPK longitudinal 4CH, ms 288 361 455 281 366 450 282 363 445
Right ventricle
RV end-diastolic volume, ml 132 196 259 128 188 247 139 188 237
RV end-systolic volume, ml 54 89 124 49 83 117 57 84 112
RV stroke volume, ml 72 105 139 69 105 140 73 104 135
Indexed RV end-diastolic volume, ml/m2 69 99 128 67 96 125 75 97 119
Indexed RV end-systolic volume, ml/m2 29 45 61 26 42 58 31 43 56
Indexed RV stroke volume, ml/m2 37 53 69 36 54 71 39 53 68
RV ejection fraction, % 46 54 62 47 56 65 46 55 64
Values are means and the lower and upper bound of the 95% prediction intervals.
2CH ¼ 2-chamber; 4CH ¼ 4-chamber; CMR ¼ cardiac magnetic resonance; LAX ¼ long-axis; LV ¼ left ventricular; RV ¼ right ventricular; SAX ¼ short-axis; TPK ¼ time to peak.
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9REFERENCE VALUES. After validation, we used our
pipeline to obtain sex-specific reference values for
the ventricular function parameters in a group of
2,029 healthy volunteers (Tables 3 and 4).
The values for cardiac volumes (EDV, ESV, SV,
and LVM) obtained using our automated method
are in correspondence with those manually ob-
tained in previous sizable studies (6,7). In addition
to these values, we also present reference values
for filling and ejection dynamics and strain. The
latter parameters have not previously been re-
ported in large cohort studies. However, our results
do correspond with the largest available study
for filling and ejection parameters (27), and ameta-analysis of normal values for CMR-derived
strain (28).
The total analysis time of the network wasw8 min/
subject. This is significantly shorter than the time
needed for manual or semiautomated segmentation
and FT of the full cardiac cycle in SAX and LAX using
the current state-of-the-art commercial software that
requires frequent manual adjustments of semi-
automated analysis in basal and apical slices of the
acquisition.
STUDY LIMITATIONS. At present, this method is
designed using data from our Department of Car-
diovascular Imaging and UK Biobank. Variability in
TABLE 4 Reference Values for Women by Automated Cine CMR Analysis
Age Groups, yrs
45–54 55–64 65–74
Lower Mean Upper Lower Mean Upper Lower Mean Upper
Left ventricle
Volumes
LV end-diastolic volume, ml 98 139 180 101 133 165 98 131 163
LV end-systolic volume, ml 34 55 76 33 51 70 34 50 66
LV stroke volume, ml 57 84 111 59 81 103 57 79 102
LV mass, g 51 71 91 52 69 87 54 70 86
Indexed LV end-diastolic volume, ml/m2 61 80 99 61 78 95 59 77 95
Indexed LV end-systolic volume, ml/m2 20 32 43 20 30 40 20 30 39
Indexed LV stroke volume, ml/m2 35 48 62 35 47 60 33 47 61
Indexed LV mass, g/m2 32 41 50 32 40 48 33 41 49
LV ejection fraction, % 51 61 70 52 61 71 52 61 70
LV mass-to-volume ratio, g/ml 0.42 0.51 0.61 0.42 0.52 0.62 0.43 0.54 0.65
Filling and ejection dynamics
Peak ejection rate, ml/s 266 386 507 263 370 477 259 363 466
Peak early filling rate, ml/s 231 364 497 207 322 436 179 302 425
Peak atrial filling rate, ml/s 54 204 355 73 223 373 82 234 386
Atrial contribution, ml 8 24 41 11 27 44 13 29 44
Atrial contribution, % of SV 13 29 44 17 33 50 20 36 51
Peak global strain
Circumferential strain SAX, % 14 20 26 14 20 26 14 20 26
TPK circumferential SAX, ms 278 356 413 279 356 416 277 357 417
Radial strain SAX, % 24 47 68 28 47 69 27 46 68
TPK radial SAX, ms 275 358 401 275 358 407 271 360 408
Longitudinal strain 2CH, % 11 17 22 10 17 22 11 17 21
TPK longitudinal 2CH, ms 277 374 451 281 374 451 277 378 458
Longitudinal strain 4CH, % 9 15 21 10 15 21 10 16 21
TPK longitudinal 4CH, ms 274 372 451 278 372 453 284 378 453
Right ventricle
RV end-diastolic volume, ml 97 142 188 101 139 176 99 132 164
RV end-systolic volume, ml 34 58 82 33 56 79 34 52 70
RV stroke volume, ml 57 84 111 60 83 106 60 80 99
Indexed RV end-diastolic volume, ml/m2 59 82 105 62 80 99 58 78 98
Indexed RV end-systolic volume, ml/m2 21 33 46 20 33 45 20 31 41
Indexed RV stroke volume, ml/m2 34 48 62 36 48 60 34 48 62
RV ejection fraction, % 50 59 68 50 60 70 54 61 68
Abbreviations as in Table 3.
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10type of CMR scanners and protocols results in
variable image-characteristics between CMR labs.
To obtain similar performance in other labora-
tories, additional training of the neural networks
in the framework is needed using data from the
new site. However, the principles, including the
hardcoded QC measures, remain valid as vital
components for automation of CMR analysis in
general. If adapted using extra training input, this
method can therefore potentially provide robust
analysis in other large datasets, research studies,
or even clinical CMR services. As part of the Open
Science initiative, our method is available for
further training and use via the corresponding
author.CONCLUSIONS
We presented and validated a pipeline for automated
analysis of cardiac function from cine CMR using DL.
Our proposed framework includes comprehensive QC
designed to detect potential erroneous results for
clinician review, allowing fully autonomous process-
ing of CMR exams. We showed that using this tool, we
were able to obtain reference values in a large cohort
(>2,000) of subjects to characterize cardiac function.
ADDRESS FOR CORRESPONDENCE: Dr. Bram Ruijsink,
The Rayne Institute 4th Floor Lambeth Wing, St Thomas
Hospital, Westminster Bridge Road, SE1 7EH London,
United Kingdom. E-mail: jacobus.ruijsink@kcl.ac.uk.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: CMR can
provide sensitive biomarkers for cardiac function.
However, analysis is time and labor intensive. DL can
automate CMR analysis, but adequate QC of the
algorithms is pivotal.
TRANSLATIONAL OUTLOOK 1: This is the first study
to develop a comprehensive method for DL-based CMR
analysis that includes extensive QC measures to flag
potential erroneous results.
TRANSLATIONAL OUTLOOK 2: We show that our
pipeline enables detailed characterization of cardiac
function in an automated and accurate way in large-scale
studies and potentially clinical practice.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . - , N O . - , 2 0 1 9 Ruijsink et al.
- 2 0 1 9 :- –- Fully Automated, Quality-Controlled Cardiac Function From Cine CMR
11RE F E RENCE S1. von Knobelsdorff-Brenkenhoff F, Pilz G, Schulz-
Menger J. Representation of cardiovascular mag-
netic resonance in the AHA / ACC guidelines.
J Cardiovasc Magn Reson 2017;19:70.
2. Medrano-Gracia P, Cowan BR, Ambale-
Venkatesh B, et al. Left ventricular shape variation
in asymptomatic populations: the Multi-Ethnic
Study of Atherosclerosis. J Cardiovasc Magn
Reson 2014;16:56.
3. Maceira A, Prasad S, Khan M, Pennell D.
Normalized left ventricular systolic and diastolic
function by steady state free precession cardio-
vascular magnetic resonance. J Cardiovasc Magn
Reson 2006;8:417–26.
4. Claus P, Omar AMS, Pedrizzetti G, Sengupta PP,
Nagel E. Tissue tracking technology for assessing
cardiac mechanics: principles, normal values, and
clinical applications. J Am Coll Cardiol Img 2015;8:
1444–60.
5. Nucifora G, Muser D, Tioni C, Shah R,
Selvanayagam JB. Prognostic value of myocardial
deformation imaging by cardiac magnetic reso-
nance feature-tracking in patients with a first ST-
segment elevation myocardial infarction. Int J
Cardiol 2018;271:387–91.
6. Petersen SE, Aung N, Sanghvi MM, et al.
Reference ranges for cardiac structure and func-
tion using cardiovascular magnetic resonance
(CMR) in Caucasians from the UK Biobank popu-
lation cohort. J Cardiovasc Magn Reson 2017;19:
18.
7. Gandy SJ, Lambert M, Belch J, et al. 3T MRI
investigation of cardiac left ventricular structure
and function in a UK population: the Tayside
Screening for the Prevention of Cardiac Events
(TASCFORCE) study. J Magn Reson Imaging 2016;
44:1186–96.
8. Litjens G, Kooi T, Bejnordi BE, et al. A survey on
deep learning in medical image analysis. Med Im-
age Anal 2017;42:60–88.
9. Suinesiaputra A, Sanghvi MM, Aung N, et al.
Fully-automated left ventricular mass and volumeMRI analysis in the UK Biobank population cohort:
evaluation of initial results. Int J Cardiovasc Im-
aging 2018;34:281–91.
10. Bai W, Sinclair M, Tarroni G, et al. Automated
cardiovascular magnetic resonance image analysis
with fully convolutional networks. J Cardiovasc
Magn Reson 2018;20:65.
11. Bernard O, Lalande A, Zotti C, et al. Deep
learning techniques for automatic MRI cardiac
multi-structures segmentation and diagnosis: is
the problem solved? IEEE Trans Med Imaging
2018;37:2514–25.
12. Thrall JH, Li X, Li Q, et al. Artificial intelligence
and machine learning in radiology: opportunities,
challenges, pitfalls, and criteria for success. J Am
Coll Radiol 2018;15 Pt B:504–8.
13. Oksuz I, Ruijsink B, Puyol-Anton E, et al. Deep
learning using K-space based data augmentation
for automated cardiac MR motion artefact detec-
tion. In: Medical Image Computing and Computer-
Assisted Intervention - MICCAI 2018. Lecture
Notes in Computer Science. Springer, 2018;11070:
250–8.
14. Oksuz I, Ruijsink B, Puyol-Anton E, et al.
Automatic left ventricular outflow tract classifi-
cation for accurate cardiac MR planning. IEEE 15th
Int Symp Biomed Imaging 2018:462–5.
15. Sinclair M, Bai W, Puyol-Antón E, Oktay O,
Rueckert D, King AP. Fully automated
segmentation-based respiratory motion correction
of multiplanar cardiac magnetic resonance images
for large-scale datasets. In Medical Image
Computing and Computer-Assisted Intervention -
MICCAI 2017. Lecture Notes in Computer Science.
Springer, 2017;10435:332–40.
16. Puyol-Anton E, Ruijsink B, Bai W, et al. Fully
automated myocardial strain estimation from
cine MRI using convolutional neural networks.
In: IEEE 15th International Symposium on
Biomedical Imaging (ISBI). Piscataway, NJ: Insti-
tute of Electrical and Electronics Engineers,
2018:1139–43.17. Petersen SE, Matthews PM, Francis JM,
et al. UK Biobank’s cardiovascular magnetic
resonance protocol. J Cardiovasc Magn Reson
2015;18:8.
18. Solberg HE. The theory of reference values
Part 5. Statistical treatment of collected reference
values. Determination of reference limits. Clin
Chim Acta 1984;137:95–114.
19. Du Bois D, Du Bois EF. A formula to esti-
mate the approximate surface area if height and
weight be known. Arch Intern Med 1916;17:
863–71.
20. Lorch B, Vaillant G, Baumgartner C,
Bai W, Rueckert D, Maier A. Automated
detection of motion artefacts in MR imaging
using decision forests. J Med Eng 2017;2017:
1–9.
21. Wu L, Cheng J-Z, Li S, Lei B, Wang T, Ni D.
FUIQA: fetal ultrasound image quality assessment
with deep convolutional networks. IEEE Trans
Cybern 2017;47:1336–49.
22. Abdi AH, Luong C, Tsang T, et al. Automatic
quality assessment of echocardiograms using
convolutional neural networks: feasibility on the
apical four-chamber view. IEEE Trans Med Imaging
2017;36:1221–30.
23. Zhang L, Frangi AF, Gooya A. Semi-super-
vised assessment of incomplete LV coverage in
cardiac MRI using generative adversarial nets. In:
Simulation and Synthesis in Medical Imaging:
Second International Workshop, SASHIMI 2017.
Cham, Switzerland: Springer International,
2017;138–45.
24. Lu X, Jolly M-P, Georgescu B, et al. Auto-
matic view planning for cardiac MRI acquisi-
tion. In: Medical Image Computing and
Computer Assisted Intervention: MICCAI 2011.
Cham, Switzerland: Springer International,
2011;479–86.
25. Robinson R, Valindria V, Bai W, et al. Auto-
matic quality control of cardiac MRI segmentation
in large-scale population imaging. In: Medical
Ruijsink et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . - , N O . - , 2 0 1 9
Fully Automated, Quality-Controlled Cardiac Function From Cine CMR - 2 0 1 9 :- –-
12Image Computing and Computer-Assisted Inter-
vention: MICCAI 2017. Cham, Switzerland:
Springer International, 2017;720–7.
26. Schuster A, Stahnke V-C, Unterberg-
Buchwald C, et al. Cardiovascular magnetic reso-
nance feature-tracking assessment of myocardial
mechanics: intervendor agreement and consider-
ations regarding reproducibility. Clin Radiol 2015;
70:989–98.27. Kawel-Boehm N, Maceira A, Valsangia-
como-Buechel ER, et al. Normal values for
cardiovascular magnetic resonance in adults
and children. J Cardiovasc Magn Reson 2015;
17:29.
28. Vo HQ, Marwick TH, Negishi K. MRI-
derived myocardial strain measures in normal
subjects. J Am Coll Cardiol Img 2018;11:
196–205.KEY WORDS cardiac aging, cardiac
function, cardiac magnetic resonance, CMR
feature tracking, machine learning, quality
control
APPENDIX For supplemental videos,
figures, and tables, please see the online
version of this paper.
